Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

$JAZZ yoy growth expected at over 700% in 2011

|Includes: ABC, ACOR, AMGN, BAX, BIIB, BMY, CEPH, DNDN, ELN, GILD, GSK, ILMN, Jazz Pharmaceuticals, Inc. (JAZZ), JNJ, LLY, MNKD, MRK, OREX, PFE, PSTI, QGEN, SGEN, SHPG, SNY, TMO, VRX, VVUS
 JAZZ closest stock to a no brainer 50% - 100% gains type potential stock for 2011
(
JAZZ) yoy growth expected at over 700% in 2011 

$1.48 eps estimate for full year 2010 (75% already known) with .61 eps expected for Q4 although JAZZ has a habit of beating estimates by a mile.

$2.38 eps estimate for 2011

Surprised how quiet wall street has managed to keep JAZZ with the type of earnings that are coming in 2011 and last qtr of 2010.

Its not everyday that you have a stock under $23 with a pending Q4 of .61 eps.